| 摘要 |
<p>An improved species specific vaccine having reduced risks of engendering autoimmune disease in vaccinated animals is described. The vaccine is formulated to be substantially free of heterologous species serum components. Preferably the species specific vaccines are produced from antigen concentrates recovered from cell culture media comprising serum wherein the serum consists essentially of homologous species serum.</p> |
